Publications by authors named "Manon Auffret"

Claim this Profile
P
Phineas Gage, in his own time: A medical case reconstructed from newly unearthed nineteenth-century archives.
Manon Auffret

J Hist Neurosci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's disease.
Manon Auffret, Fran Borovecki, Beatrice Heim, Wolfgang H Jost, Per Odin

J Neural Transm (Vienna)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marcelle lapicque (1873-1960): The first black female European neuroscientist?
Alison Christy, Manon Auffret, Jean-Gaël Barbara, Alexis Simpkins

J Natl Med Assoc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Other clinical uses for apomorphine: Sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury, sexual dysfunction.
Marc Vérin, Manon Auffret

Parkinsonism Relat Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apomorphine: past, present and future in Parkinson's disease and beyond.
Manon Auffret

Parkinsonism Relat Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Management of Parkinson's Disease Before, during and after Pregnancy-an MDS Scientific Issues Committee Review.
Alexander C Lehn, Jee-Young Lee, Giorgia Sciacca, Stacy Patterson, Adam Morton, Manon Auffret

Mov Disord Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Priorities in Neuropalliative Care: A Consensus Statement From the International Neuropalliative Care Society.
Winnie K Lau, Corey R Fehnel, Zachary A Macchi, Ambereen K Mehta, Manon Auffret

JAMA Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.
Onanong Phokaewvarangkul, Manon Auffret, Sergiu Groppa, Vladana Markovic, Igor Petrovic

J Neural Transm (Vienna)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting creative behavior using resting-state electroencephalography.
Fatima Chhade, Judie Tabbal, Véronique Paban, Manon Auffret, Mahmoud Hassan

Commun Biol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Electrophysiological signatures of anxiety in Parkinson's disease.
Sahar Yassine, Sourour Almarouk, Ute Gschwandtner, Manon Auffret, Peter Fuhr

Transl Psychiatry· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Parkinson's disease: intrinsically palliative care].
Manon Auffret, Marc Vérin, Mathilde Giffard, Delphine Marguet, Matthieu Béreau

Soins· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terminal Care in Parkinson's Disease: Real-Life Use of Continuous Subcutaneous Apomorphine Infusion to Improve Patient Comfort.
Matthieu Béreau, Mathilde Giffard, Anne-Laure Clairet, Guillaume Degenne, Laurent Tatu, Manon Auffret

J Parkinsons Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrophysiological signatures of anxiety in Parkinson's disease.
Sahar Yassine, Sourour Almarouk, Ute Gschwandtner, Manon Auffret, Peter Fuhr

Transl Psychiatry· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty.
Manon Auffret, Daniel Weiss, Fabrizio Stocchi, Marc Vérin, Wolfgang H Jost

J Neural Transm (Vienna)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Parkinson's Disease Subtypes from Resting-State Electroencephalography.
Sahar Yassine, Ute Gschwandtner, Manon Auffret, Joan Duprez, Marc Verin

Mov Disord· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Brain Dysconnectivity in Parkinson's Disease: A 5-Year Longitudinal Study.
Sahar Yassine, Ute Gschwandtner, Manon Auffret, Sophie Achard, Marc Verin

Mov Disord· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oral antiparkinsonian treatments, nursing practices in Ehpad].
Stéphanie Mazé, Aline Corvol, Manon Auffret

Soins Gerontol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Health Disorders in Parkinson's Disease: More than Meets the Eye.
Manon Auffret, Vincent Meuric, Emile Boyer, Martine Bonnaure-Mallet, Marc Vérin

J Parkinsons Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French Validation of the Alcohol Urge Questionnaire: Psychometric Properties and Relationship with Alcohol Dependence and Drinking Behavior.
Aymery Constant, Marlene Sanz, Manon Auffret, Florian Naudet, Marc Vérin

Alcohol Alcohol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New tricks for an old dog: A repurposing approach of apomorphine.
Manon Auffret, Sophie Drapier, Marc Vérin

Eur J Pharmacol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.
Manon Auffret, Sophie Drapier, Marc Vérin

Drugs R D· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.
Manon Auffret, Sophie Drapier, Marc Vérin

Drugs R D· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.
Manon Auffret, Sophie Drapier, Marc Vérin

Clin Drug Investig· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.
Joan Duprez, Jean-François Houvenaghel, Sophie Drapier, Manon Auffret, Dominique Drapier

J Neurol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.
Manon Auffret, Florence Le Jeune, Anne Maurus, Sophie Drapier, Jean-François Houvenaghel

J Neurol Sci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis